Published in Curr Opin Genet Dev on February 01, 2000
Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol (2010) 4.23
PML is induced by oncogenic ras and promotes premature senescence. Genes Dev (2000) 3.35
Telomeres, stem cells, senescence, and cancer. J Clin Invest (2004) 2.87
Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev (2000) 2.38
Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol (2002) 2.25
Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc Natl Acad Sci U S A (2004) 1.83
TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Mol Cell Biol (2002) 1.80
Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions. Mol Cell Biol (2001) 1.72
The telomerase-recruitment domain of the telomere binding protein Cdc13 is regulated by Mec1p/Tel1p-dependent phosphorylation. Nucleic Acids Res (2006) 1.71
Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis. Cancer Cell (2009) 1.67
The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50
Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res (2011) 1.49
Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol (2004) 1.44
Genomic instability in breast cancer: pathogenesis and clinical implications. Mol Oncol (2010) 1.43
Cdc13 prevents telomere uncapping and Rad50-dependent homologous recombination. EMBO J (2001) 1.41
A mouse model of human oral-esophageal cancer. J Clin Invest (2002) 1.40
Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis (2003) 1.39
Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology (2004) 1.32
Involvement of replicative polymerases, Tel1p, Mec1p, Cdc13p, and the Ku complex in telomere-telomere recombination. Mol Cell Biol (2002) 1.23
Assessing cell and organ senescence biomarkers. Circ Res (2012) 1.17
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer. J Clin Invest (2002) 1.14
Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability. Neoplasia (2002) 1.12
Telomere loss provokes multiple pathways to apoptosis and produces genomic instability in Drosophila melanogaster. Genetics (2008) 1.10
Rearrangements of ribosomal DNA clusters in late generation telomerase-deficient Arabidopsis. Chromosoma (2003) 1.10
The N-terminus of hTERT contains a DNA-binding domain and is required for telomerase activity and cellular immortalization. Nucleic Acids Res (2009) 1.05
Understanding telomere diseases through analysis of patient-derived iPS cells. Curr Opin Genet Dev (2013) 1.03
Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres. Br J Cancer (2002) 1.03
Rapid Cdc13 turnover and telomere length homeostasis are controlled by Cdk1-mediated phosphorylation of Cdc13. Nucleic Acids Res (2009) 1.01
Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat Genet (2016) 1.01
Selective pressures for and against genetic instability in cancer: a time-dependent problem. J R Soc Interface (2008) 1.00
Telomere attrition in isolated high-grade prostatic intraepithelial neoplasia and surrounding stroma is predictive of prostate cancer. Neoplasia (2007) 1.00
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol (2015) 0.99
Extrachromosomal telomeric circles contribute to Rad52-, Rad50-, and polymerase delta-mediated telomere-telomere recombination in Saccharomyces cerevisiae. Eukaryot Cell (2005) 0.99
Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer. Mol Cancer (2011) 0.97
Making the most of a little: dosage effects in eukaryotic telomere length maintenance. Chromosome Res (2005) 0.95
The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studies. BMC Cancer (2012) 0.93
A genomics approach identifies senescence-specific gene expression regulation. Aging Cell (2014) 0.92
Altered states of telomere deprotection and the two-stage mechanism of replicative aging. Mol Cell Biol (2009) 0.91
Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol (2015) 0.90
Differential roles of telomere attrition in type I and II endometrial carcinogenesis. Am J Pathol (2008) 0.89
RNF4 interacts with both SUMO and nucleosomes to promote the DNA damage response. EMBO Rep (2014) 0.87
Genetic dissection of the mechanisms underlying telomere-associated diseases: impact of the TRF2 telomeric protein on mouse epidermal stem cells. Dis Model Mech (2009) 0.87
A G-quadruplex stabilizer induces M-phase cell cycle arrest. J Biol Chem (2009) 0.87
Role of nicotine dependence on the relationship between variants in the nicotinic receptor genes and risk of lung adenocarcinoma. PLoS One (2014) 0.86
Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. Br J Cancer (2004) 0.84
Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes. Mod Pathol (2010) 0.83
Can a single model explain both breast cancer and prostate cancer? Theor Biol Med Model (2007) 0.83
Cause-specific telomere factors deregulation in hepatocellular carcinoma. J Exp Clin Cancer Res (2013) 0.83
A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes. Retrovirology (2005) 0.82
High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma. Neoplasia (2002) 0.82
Chk2 and p53 are haploinsufficient with dependent and independent functions to eliminate cells after telomere loss. PLoS Genet (2011) 0.81
Senescence of nucleus pulposus chondrocytes in human intervertebral discs. Asian Spine J (2008) 0.80
Moderate expression of TRF2 in the hematopoietic system increases development of large cell blastic T-cell lymphomas. Aging (Albany NY) (2009) 0.80
Mitochondrial dysfunction and oxidative stress in aging and cancer. Oncotarget (2016) 0.80
Fastest time to cancer by loss of tumor suppressor genes. Bull Math Biol (2014) 0.79
A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERT. J Cutan Pathol (2014) 0.76
New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids. Acta Naturae (2009) 0.75
Telomeres in aging and disease: lessons from zebrafish. Dis Model Mech (2016) 0.75
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell (1997) 13.34
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Role of the INK4a locus in tumor suppression and cell mortality. Cell (1996) 11.41
ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell (1991) 9.54
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell (1998) 8.33
Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature (1997) 7.66
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (2000) 7.28
Essential role of mouse telomerase in highly proliferative organs. Nature (1998) 7.23
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature (2001) 7.06
Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell (1999) 6.98
Malignant glioma: genetics and biology of a grave matter. Genes Dev (2001) 6.78
Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51
p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell (1999) 5.93
Cellular senescence: mitotic clock or culture shock? Cell (2000) 5.17
A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature (1986) 4.95
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (1997) 4.82
Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature (2000) 4.75
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (1994) 4.52
Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity (2001) 4.09
DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell (2000) 3.82
An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell (1995) 3.68
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev (1998) 3.68
Regulation of genome rearrangement events during lymphocyte differentiation. Immunol Rev (1986) 3.65
N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev (2000) 3.62
The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev (1999) 3.50
Human N-myc is closely related in organization and nucleotide sequence to c-myc. Nature (1986) 3.40
The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci U S A (2000) 3.21
Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet (2001) 2.92
Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science (2000) 2.67
Secondary genomic rearrangement events in pre-B cells: VHDJH replacement by a LINE-1 sequence and directed class switching. EMBO J (1986) 2.62
Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene (1998) 2.49
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev (1997) 2.47
Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell (1999) 2.46
Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science (1995) 2.42
Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev (1998) 2.39
Structure and expression of the murine N-myc gene. Proc Natl Acad Sci U S A (1986) 2.36
Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet (2000) 2.34
Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene (1999) 2.34
Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene (1998) 2.27
Gene-target recognition among members of the myc superfamily and implications for oncogenesis. Nat Genet (2000) 2.19
DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol (2001) 2.09
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev (2000) 1.87
Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol Biol Cell (2001) 1.85
Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature (1998) 1.82
p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci U S A (2001) 1.75
Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc Natl Acad Sci U S A (1997) 1.74
p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Proc Natl Acad Sci U S A (1998) 1.73
Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol (2001) 1.73
Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev (1992) 1.68
Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol Cell (2001) 1.68
Malignant melanoma: modern black plague and genetic black box. Genes Dev (1998) 1.67
The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends Biochem Sci (1998) 1.59
Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc Natl Acad Sci U S A (1994) 1.56
Essential role for Max in early embryonic growth and development. Genes Dev (2000) 1.46
Repression by the Mad(Mxi1)-Sin3 complex. Bioessays (1998) 1.45
Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci U S A (1998) 1.41
Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. Proc Natl Acad Sci U S A (1997) 1.37
Expression and activity of L-Myc in normal mouse development. Mol Cell Biol (1996) 1.36
The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine (Baltimore) (1985) 1.35
Mice without telomerase: what can they teach us about human cancer? Nat Med (2000) 1.33
Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat Med (1995) 1.32
Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc Natl Acad Sci U S A (1995) 1.26
Human CPR (cell cycle progression restoration) genes impart a Far- phenotype on yeast cells. Genetics (1997) 1.25
Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin Cancer Biol (1994) 1.23
Voltage-activated K+ channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells. J Neurosci (1999) 1.20
Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. Nucleic Acids Res (1999) 1.17
Neurotransmitter receptor activation triggers p27(Kip1 )and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors. Development (1999) 1.14
Myc and Max: a putative transcriptional complex in search of a cellular target. Curr Opin Cell Biol (1992) 1.13
Comparative analysis of the expression and oncogenic activities of Xenopus c-, N-, and L-myc homologs. Mol Cell Biol (1993) 1.07
Zebra fish myc family and max genes: differential expression and oncogenic activity throughout vertebrate evolution. Mol Cell Biol (1993) 1.07
Tetracycline-inducible system for photoreceptor-specific gene expression. Invest Ophthalmol Vis Sci (2000) 1.03
Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo. EMBO J (1995) 1.02
Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. Semin Cancer Biol (2001) 1.01
Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit. Curr Biol (2001) 1.01
Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc Natl Acad Sci U S A (2001) 1.00
Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility. Mol Cell Biol (2001) 0.98
Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Cancer Res (2001) 0.97
Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1. Oncogene (1996) 0.97
Animal models of melanoma: recent advances and future prospects. Adv Cancer Res (2000) 0.96
Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1. Oncogene (1994) 0.95
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model. Semin Cancer Biol (2001) 0.93
Transcriptional repression. The cancer-chromatin connection. Nature (1998) 0.92
Role of first exon/intron sequences in the regulation of myc family oncogenic potency. Oncogene (1993) 0.89
Unlimited mileage from telomerase? Science (1999) 0.89
Structural and functional analysis of the mouse mdr1b gene promoter. J Biol Chem (1991) 0.88
The glucocorticoid hormone signal transduction pathway in mice homozygous for chromosomal deletions causing failure of cell type-specific inducible gene expression. Proc Natl Acad Sci U S A (1991) 0.87
Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Mol Cell Biol (1999) 0.87
Complex transcriptional regulation of myc family gene expression in the developing mouse brain and liver. Mol Cell Biol (1991) 0.87
Telomere-dependent senescence. Nat Biotechnol (1999) 0.86
The interplay between nonhomologous end-joining and cell cycle checkpoint factors in development, genomic stability, and tumorigenesis. Cold Spring Harb Symp Quant Biol (2000) 0.85
Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans. Gastroenterology (1984) 0.85
Flipping the oncogene switch: illumination of tumor maintenance and regression. Trends Genet (2000) 0.84
Lens complementation system for the genetic analysis of growth, differentiation, and apoptosis in vivo. Proc Natl Acad Sci U S A (1996) 0.83
Tumorigenic and developmental effects of combined germ-line mutations in Rb and p53. Cold Spring Harb Symp Quant Biol (1994) 0.83
Loss of transcriptional attenuation in N-myc is associated with progression towards a more malignant phenotype. Oncogene (1995) 0.83
Modeling prostate cancer in the mouse. Adv Cancer Res (2001) 0.83
Functional interactions among members of the Myc superfamily and potential relevance to cutaneous growth and development. J Investig Dermatol Symp Proc (1996) 0.82
Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc. Oncogene (1999) 0.80
Tailor-made monoclonal antibodies. Ann Intern Med (1986) 0.80
Cancer. Telomerase meets its mismatch. Nature (2001) 0.79